The global market for oxygen therapy products predicted to reach $7.1 billion by 2029, growing at a CAGR of 8.6% over the forecast period, driven by increasing prevalence of respiratory diseases as well as chronic and acute disorders worldwide.
- Other significant factors driving the oxygen therapy market growth include rise in incidence of COPD and other respiratory diseases, increasing patient preference for portable and home-based oxygen therapy products, and technological advancement in respiratory care.
Oxygen administration is routinely utilized on the majority of patients admitted the emergency room or ICU with respiratory distress. Indications for oxygen administration include, hypoxemia, increased working of breathing, and hemodynamic insufficiency.
- The medical treatment can be used in both chronic and acute cases either in hospital, pre-hospital or entirely out of hospital.
- A common use of supplementary oxygen is in patients with chronic obstructive pulmonary disease (COPD), or acute conditions such as resuscitation, major trauma, anaphylaxis, major hemorrhage, shock, active convulsions and hypothermia.
Oxygen delivery devices are categorized into three basic types based on their design: low-flow, reservoir, and high-flow.
- Low-flow oxygen systems provide supplemental oxygen often less than the patient’s total minute ventilation.
- Reservoir systems incorporate a mechanism for gathering and storing oxygen during inspiration and exhalation.
- High-flow oxygen delivery systems supply a given oxygen concentration at a flow equaling or exceeding the patient’s inspiratory flow demand.
- Currently, there is a wide array of oxygen delivery devices available to the respiratory therapist to utilize for administration. The choice of oxygen delivery devices depends on the patient’s oxygen requirement, efficacy of the device, reliability, ease of therapeutic application and patient acceptance.
- Oxygen therapy devices are used to treat end-stage COPD where the patient is no longer naturally receiving enough oxygen. COPD includes chronic obstructive bronchitis and emphysema.
The global oxygen therapy devices market report estimates the market size ($million 2019 to 2029), market share, market trends and forecast (CAGR% 2023 to 2029).
The global market for oxygen therapy devices segmented by product [oxygen source equipment (liquid oxygen devices, oxygen concentrators, oxygen cylinders); oxygen delivery devices (bag valve masks, continuous positive airway pressure/ CPAP masks, nasal cannulas, non-rebreathers, simple oxygen masks and venturi masks)], by application (asthma, COPD, cystic fibrosis, obstructive sleep apnea, pneumonia, and respiratory distress syndrome).
- Among the major products segment, the oxygen source equipment accounted for the largest share of total market, while the oxygen delivery devices forecast to grow at a slightly faster CAGR during the forecast period.
- Out of the oxygen source equipment market segment, the oxygen concentrator sub-segment accounted for the largest share of the global market, while the liquid oxygen devices sub-segment forecast to grow at the fastest rate over the next five year period.
- The benefits of oxygen concentrators include continuous flow of oxygen with up to 95% pure oxygen, self-generating units that do not require refilling and fairly low-maintenance devices, requiring only monthly follow-ups and routine maintenance.
- The liquid oxygen storage method takes up less space than the compressed gas cylinder, and the liquid can be transferred to a small, portable vessel.
- The benefits of oxygen concentrators include continuous flow of oxygen with up to 95% pure oxygen, self-generating units that do not require refilling and fairly low-maintenance devices, requiring only monthly follow-ups and routine maintenance.
- By oxygen delivery devices market segment, the simple oxygen masks sub-segment registered maximum sales revenue, while the venturi masks sub-segment anticipated to grow at the fastest rate over the forecast period.
- Based on the applications, the rise in COPD and significant technological advancement in development of novel respiratory devices led to the fastest market growth and market share in the total oxygen therapy market.
- The major advantages of oxygen therapy include control of COPD complications, improving survival, greater exercise tolerance and improvement of the overall quality of life.
The global oxygen delivery devices market research report is divided by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.
- Geographically, the North America region dominated the global market for oxygen therapy devices, followed by Europe with moderate growth rate throughout the forecast period.
- Increasing prevalence of chronic obstructive pulmonary diseases, technological advances and focus on patient care are driving the market growth in developed regions.
- On the other hand, the Asia Pacific region predicted to register the fastest CAGR over the forecast period, owing to rise in the geriatric population, increase in the prevalence of chronic respiratory diseases, and favorable government policies.
The global oxygen therapy systems market research report also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
Major Competitors operating in the global market for oxygen therapy products and included in this report are Becton, Dickinson and Company (CareFusion Corporation), Chart Industries (AirSep Corporation), DeVilbiss Healthcare, LLC (Drive DeVilbiss International), Fisher & Paykel Healthcare Limited, Invacare Corporation, MAQUET Holding B.V. & Co. KG, Philips Respironics, Inc., Smiths Medical, and Teleflex Incorporated.
- Product
- Oxygen Source Equipment
- Liquid Oxygen Devices
- Oxygen Concentrators
- Oxygen Cylinders
- Oxygen Delivery Devices
- Bag Valve Masks (BVMs)
- Continuous Positive Airway Pressure (CPAP) Masks
- Nasal Cannulas
- Non-Rebreathers
- Simple Oxygen Masks
- Venturi Masks
- Oxygen Source Equipment
- Application
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Cystic Fibrosis
- Obstructive Sleep Apnea
- Pneumonia
- Respiratory Distress Syndrome
- Geography
- North America (U.S., Canada)
- Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
- Asia Pacific (Japan, China, India, Rest of APAC)
- Latin America (Brazil, Mexico, Rest of LA)
- Rest of the World
- Company Profiles
- Becton, Dickinson and Company (CareFusion Corporation)
- Chart Industries (AirSep Corporation)
- DeVilbiss Healthcare LLC (Drive DeVilbiss International)
- Fisher & Paykel Healthcare Limited
- Invacare Corporation
- Inogen, Inc.
- MAQUET Holding B.V. & Co. KG.
- Koninklijke Philips N.V.
- ResMed
- Smiths Medical
- Teleflex Incorporated
To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/oxygen-therapy-devices-market/
Related publications:
